LAR-VAC
LAR-VAC
Authorised
- Avian infectious laryngotracheitis virus, strain Gelenczei-Marty, Live
Product identification
Medicine name:
LAR-VAC
Active substance:
- Avian infectious laryngotracheitis virus, strain Gelenczei-Marty, Live
Target species:
-
Chicken
Route of administration:
-
Oculonasal use
Product details
Active substance and strength:
-
Avian infectious laryngotracheitis virus, strain Gelenczei-Marty, Live3.20/log10 50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oculonasal suspension
Withdrawal period by route of administration:
-
Oculonasal use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD08
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Italy
Package description:
- Available only in Italian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Fatro S.p.A.
Responsible authority:
- Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022